CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway.
about
Gene expression before HAART initiation predicts HIV-infected individuals at risk of poor CD4+ T-cell recoveryAnalysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cellEvaluation of gene expression classification studies: factors associated with classification performanceAssociation of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).A curated transcriptome dataset collection to investigate the immunobiology of HIV infection.
P2860
CD4+ T-cell decline after the interruption of antiretroviral therapy in ACTG A5170 is predicted by differential expression of genes in the ras signaling pathway.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
CD4+ T-cell decline after the ...... in the ras signaling pathway.
@ast
CD4+ T-cell decline after the ...... in the ras signaling pathway.
@en
type
label
CD4+ T-cell decline after the ...... in the ras signaling pathway.
@ast
CD4+ T-cell decline after the ...... in the ras signaling pathway.
@en
prefLabel
CD4+ T-cell decline after the ...... in the ras signaling pathway.
@ast
CD4+ T-cell decline after the ...... in the ras signaling pathway.
@en
P2093
P2860
P356
P1476
CD4+ T-cell decline after the ...... in the ras signaling pathway.
@en
P2093
Amy Krambrink
Daniel J Skiest
Martin E Nau
Maryanne T Vahey
Zhaohui Su
Zhining Wang
P2860
P304
P356
10.1089/AID.2008.0059
P577
2008-08-01T00:00:00Z